#USA #Fremont, California #Alamar Biosciences #NULISA #Certified Service Provider

Alamar Biosciences Launches CSP Program for NULISA Technology

Alamar Biosciences, renowned for its innovative contributions to precision proteomics, has unveiled the Certified Service Provider (CSP) Program. This initiative notably enhances the availability of NULISA™ assays, facilitating groundbreaking research in both academic and biopharmaceutical settings.

The NULISA™ Platform, celebrated for its attomolar sensitivity, represents a remarkable advancement in the realm of proteomic analysis. It boasts the capability for unparalleled biomarker detection and quantification, setting a new standard in the industry and promising transformative outcomes in disease diagnosis and monitoring.

The CSP Program is designed to provide researchers with a scalable and cost-effective means of accessing Alamar's cutting-edge technology. This program aligns with Alamar's commitment to supporting scientists by partnering with distinguished service providers. By doing so, researchers gain enhanced flexibility and access to world-class analytical services, positioning them to undertake complex and high-throughput needs.

As of now, six distinguished laboratories have achieved CSP certification and are actively engaging in research projects. Here's a closer look at these certified service providers:

• - Biognosys (Switzerland/USA): A specialty proteomics CRO that utilizes advanced mass spectrometry and multiplex assays to deliver precise proteome quantification. They are instrumental in exploring insights from biomarker discovery to clinical trial monitoring.
• - Banner Health (Arizona, USA): This research facility is focused on tackling neurodegenerative diseases, including Alzheimer's, Parkinson's, and Lewy body dementias, contributing significantly to our understanding and treatment strategies for these conditions.
• - Emtherapro (Georgia, USA): Dedicated to advancing the discovery and validation of novel biomarkers, Emtherapro's work contributes to risk profiling, diagnosis, monitoring, and safety assessments in medical research.
• - ESYA Labs (UK/USA): Known for its multi-modal diagnostic solutions, ESYA Labs specializes in brain health screening, a crucial area in neurological research.
• - Frontage Labs: This provider offers a comprehensive suite of services for biomarker assay development, validation, and sample analysis, supporting a wide range of clinical applications.
• - Sapient (San Diego, USA): This laboratory stands out for offering comprehensive multi-omics solutions, including proteomics and metabolomics. Their work is pivotal for target identification and biomarker discovery in clinical development.

Dr. Yuling Luo, Founder, Chairman, and CEO of Alamar Biosciences, expressed his enthusiasm about the launch, stating, “We are thrilled to introduce the Certified Service Provider Program, aiming to make our NULISA technology more accessible to the research community. Collaborating with trusted service providers ensures that researchers have the critical support needed for groundbreaking advancements in protein biomarker research.”

The inception of the CSP Program marks a significant achievement for Alamar, aligning with its broader goals of accelerating scientific progress through innovative assay solutions and facilitating collaborations that can lead to pivotal discoveries in biological research.

Researchers opting to engage with certified partners can pursue their projects with confidence, knowing they are partnering with laboratories recognized for meeting Alamar's stringent standards for quality and performance. This move not only opens up broader access to cutting-edge proteomic capabilities but also empowers scientists to explore and uncover vital research insights.

Alamar Biosciences continues to position itself at the forefront of life sciences innovations with its proprietary NULISA™ Platform, which operates seamlessly alongside the ARGO™ HT System to achieve unparalleled detection sensitivities not matched by any existing technologies in the market. For detailed information and further inquiries, interested parties can visit alamarbio.com.

In conclusion, the Certified Service Provider Program represents a promising era for research in proteomics, illustrating Alamar Biosciences’ commitment to equipping the scientific community with the tools necessary for impactful discoveries.